Search for a clinical trial
Other search option(s)
6 Result(s)
Recruiting trial
= 
; Ongoing trial
= 
; Funded by an IRDiRC member = 
National clinical trial(s)
BELGIUM
ARRONDISSEMENT BRUSSELS-CAPITAL
ADDRESS: NOT PROVIDED - BE
CREATE (EORTC-90101): Cross-tumoral Phase 2 clinical trial exploring Crizotinib (PF-02341066) in patients with advanced tumor induced by causal alterations of ALK and/or MET - BE
Institution: Information not provided - BE
ESTONIA
Tartu
TARTU
Phase III study to evaluate GW786034 (Pazopanib) In Metastatic Renal Cell Carcinoma
Tartu University Hospital
Haematology and Oncology Clinic
GERMANY
Niedersachsen
HANNOVER
RAPTOR/LFR08: A single arm, multicenter phase II trial of RAD001 as monotherapy in the treatment of advanced Papillary Renal Cell Cancer
Medizinische Hochschule Hannover
Klinik für Hämatologie, Hämostaseologie, Onkologie und Stammzelltransplantation
UNITED KINGDOM
Greater London
LONDON
CREATE (EORTC 90101): Cross-tumoral Phase 2 clinical trial exploring Crizotinib (PF-02341066) in patients with advanced tumours induced by causal alterations of either ALK or MET - UK
UCLH NHS Foundation Trust - University College Hospital
The London Sarcoma Service
UNITED KINGDOM
Greater Manchester
ADDRESS: NOT PROVIDED - UK
CRAD001LFR08: A single arm, multicenter phase II trial of RAD001 as monotherapy in the treatment of advanced Papillary Renal Cell Cancer - UK
Institution: Information not provided - UK
UNITED KINGDOM
Greater Manchester
MANCHESTER